Intra-arterial delivery of endostatin gene to brain tumors prolongs survival and alters tumor vessel ultrastructure
Open Access
- 27 May 2004
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 11 (16) , 1283-1289
- https://doi.org/10.1038/sj.gt.3302287
Abstract
Glioblastoma multiforme (GBM) is an incurable malignant brain tumor, usually fatal within 1 year of diagnosis. Using a syngeneic rat 9L gliosarcoma model, we have developed a novel drug delivery method in which naked plasmid DNA is selectively targeted to brain tumors via intra-arterial injection. Using a plasmid encoding the antiangiogenic endostatin, transgene expression can be detected in tumor cells in vivo, and therapeutic efficacy is observed. Administration of this plasmid resulted in an 80% tumor volume reduction 1 week after treatment and enhanced survival time by up to 47%. Treated tumors exhibited a 40% decrease in the number of tumor vessels; ultrastructural analysis of remaining tumor vessels demonstrated a number of changes including markedly narrowed or collapsed lumens. We conclude that intra-arterial injection of plasmids selectively targets therapeutic genes to CNS neoplasms. This method of gene therapy holds promise for the treatment of these highly malignant brain tumors.Keywords
This publication has 22 references indexed in Scilit:
- Factors influencing tumour cell and vascular proliferation in glioblastomaNeuropathology and Applied Neurobiology, 2002
- Tumor Hepatocytes and Basement Membrane-Producing Cells Specifically Express Two Different Forms of the Endostatin Precursor, Collagen Xviii, in Human Liver CancersHepatology, 2001
- The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healingThe FASEB Journal, 2000
- Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastasesProceedings of the National Academy of Sciences, 2000
- New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGFOncogene, 1999
- Intraarterial Delivery of Adenovirus Vectors and Liposome-DNA Complexes to Experimental Brain NeoplasmsHuman Gene Therapy, 1999
- Selective delivery of herpes virus vectors to experimental brain tumors using RMP-7Cancer Gene Therapy, 1999
- Selective Uptake of Viral and Monocrystalline Particles Delivered Intra-Arterially to Experimental Brain NeoplasmsHuman Gene Therapy, 1995
- Gene Therapy for Brain TumorsBrain Pathology, 1995
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995